ArticleFrontiers in pharmacology2021

Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice.

Chang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.